Delcath Systems Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:1987
Lead Investor(s):N/A

Employee Data

  • Delcath Systems has 36 Employees.
  • Delcath Systems currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A686N/AN/A-N/A
#2
$372.5M1853N/AN/A-N/A
#3
$38.2M190N/AN/A-N/A
#4
N/A36N/AN/A-N/A
#5
$22.1M11024%N/A-N/A
#6
$581.3M2892N/AN/A-N/A
#7
$13.5M67N/AN/A-N/A
#8
$43.4M216N/AN/A-N/A
#9
$15.1M7510%N/A-N/A
#10
$47.4M23615%N/A4.2/5N/A
Missing a competitor? Contribute!?
Submit

Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Our proprietary product-Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS)-is designed to administer high dose chemotherapy to the liver, while controlling the systemic exposure to those agents. The Company's principal focus is on the treatment of primary and metastatic liver cancers. In the United States, the Melphalan/HDS system is considered a combination drug and device product, and is regulated as a drug by the United States Food and Drug Administration (FDA). The Melphalan/HDS system has not been approved for sale in the United States. In Europe

keywords:N/A

36

Number of Employees

N/A

Revenue (est)

1

Current Jobs

N/A

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$5.2M3633%N/A-N/A
#2
N/A36N/AN/A-N/A
#3
$8.2M3633%N/A-N/A
#4
$8.2M369%$876.7M-N/A
#5
N/A3624%N/A-N/A